Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serum calcium-decreasing factor, caldecrin, inhibits receptor activator of NF-κB ligand (RANKL)-mediated Ca2+ signaling and actin ring formation in mature osteoclasts via suppression of Src signaling pathway.
Tomomura M, Hasegawa H, Suda N, Sakagami H, Tomomura A. Tomomura M, et al. Among authors: tomomura a. J Biol Chem. 2012 May 25;287(22):17963-74. doi: 10.1074/jbc.M112.358796. Epub 2012 Mar 29. J Biol Chem. 2012. PMID: 22461633 Free PMC article.
Recently, we reported that serum calcium-decreasing factor, caldecrin, which is a secretory-type serine protease isolated from the pancreas, inhibits osteoclast differentiation by suppression of NFATc1 activity regardless of its own protease activity (Hasegawa, H., Kido, S …
Recently, we reported that serum calcium-decreasing factor, caldecrin, which is a secretory-type serine protease isolated from the pa …
Serum calcium-decreasing factor, caldecrin, inhibits osteoclast differentiation by suppression of NFATc1 activity.
Hasegawa H, Kido S, Tomomura M, Fujimoto K, Ohi M, Kiyomura M, Kanegae H, Inaba A, Sakagami H, Tomomura A. Hasegawa H, et al. Among authors: tomomura a, tomomura m. J Biol Chem. 2010 Aug 13;285(33):25448-57. doi: 10.1074/jbc.M109.068742. Epub 2010 Jun 14. J Biol Chem. 2010. PMID: 20547767 Free PMC article.
Caldecrin/chymotrypsin C is a novel secretory-type serine protease that was originally isolated as a serum calcium-decreasing factor from the pancreas. Previously, we reported that caldecrin suppressed the bone-resorbing activity of rabbit mature osteoclasts (Tom …
Caldecrin/chymotrypsin C is a novel secretory-type serine protease that was originally isolated as a serum calcium-decreasing …
Molecular cloning and expression of serum calcium-decreasing factor (caldecrin).
Tomomura A, Tomomura M, Fukushige T, Akiyama M, Kubota N, Kumaki K, Nishii Y, Noikura T, Saheki T. Tomomura A, et al. Among authors: tomomura m. J Biol Chem. 1995 Dec 22;270(51):30315-21. doi: 10.1074/jbc.270.51.30315. J Biol Chem. 1995. PMID: 8530454 Free article.
We previously reported on the purification of a serum calcium-decreasing factor, referred to as caldecrin, from porcine pancreas, that is thought to be a serine protease (Tomomura, A., Fukushige, T., Noda, T., Noikura, T., and Saheki, T. (1992) FEBS Le …
We previously reported on the purification of a serum calcium-decreasing factor, referred to as caldecrin, from porcine pancreas, tha …
New biological activity of Rhinacanthus nasutus extracts.
Horii H, Ueda JY, Tamura M, Sakagami H, Tomomura M, Tomomura A, Shirataki Y. Horii H, et al. Among authors: tomomura a, tomomura m. In Vivo. 2011 May-Jun;25(3):367-73. In Vivo. 2011. PMID: 21576409
58 results